Global Pediatric Brain Tumor Market

Pediatric Brain Tumor Comprehensive Study by Type (Gliomas, Mixed neuronal-glial tumors, Embryonal tumors, Choroid plexus papilloma/carcinoma, Non-neuroepithelial tissue tumors, Meningeal Tumors, Others), Application (Hospitals And Clinics, Medical Research Centers, Academic Institutes, Others), Diagnosis (Imaging Tests, Brain or Spinal Cord Tumor Biopsy, Others), Surgery (Therapies, Drug treatment, Others) Players and Region - Global Market Outlook to 2030

Pediatric Brain Tumor Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Pediatric Brain Tumor
A pediatric brain tumor is a type of abnormal or uncontrolled growth of the normal cell in the brain or the tissue and structures that are near to it. There are different types of tumors exist, some of the cancerous (malignant) and some of the non-cancerous (benign). It is the most common type of prevalence in childhood and comprises about 25% of childhood cancer.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR4.2%


Major players are funding a large amount of money on research and also adopting collaboration strategy to capture the major market share. The main business of major players is coming from developed regions like North America and Europe. Due to rising of products and therapies, these players are looking at Asia Pacific region for future prospects. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Pediatric Brain Tumor market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott. (United States), AbbVie Inc. (United States), Akorn, Inc. (United States), Agios, Inc. (United States), Baxter (United States), Bayer AG (United States), Epizyme, Inc. (United States), Novartis AG (Switzerland) and Mylan N.V. (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Pediatric Brain Tumor market by Type (Gliomas, Mixed neuronal-glial tumors, Embryonal tumors, Choroid plexus papilloma/carcinoma, Non-neuroepithelial tissue tumors, Meningeal Tumors and Others), Application (Hospitals And Clinics, Medical Research Centers, Academic Institutes and Others) and Region.



On the basis of geography, the market of Pediatric Brain Tumor has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Diagnosis , the sub-segment i.e. Imaging Tests will boost the Pediatric Brain Tumor market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Surgery, the sub-segment i.e. Therapies will boost the Pediatric Brain Tumor market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers:
The Cases of Pediatric Tumors Are Increasing Globally, Advanced Diagnostic Technology and New Treatments, Rising Healthcare Infrastructure, Extended Insurance Cover, Government Initiatives and Emerging Economies

Challenges:
The High cost Associated with Pediatrics Brain Tumor Treatment

Opportunities:
Latest Technological Advancements

Companies are highly dependent on FDA approvals. Recently, the world’s one of the top pharmaceutical company, AbbVie has received FDA grant for rare pediatric disease designation for ABT-414, that can be used for the treatment of pediatric brain tumor.


Key Target Audience
Pediatric brain tumor diagnostic devices manufacturers, Pediatric brain tumor medicine and treatment providers, Hospitals and clinics, Medical Research Laboratories, Research and Development (R&D) Companies, Market Research and Consulting Service Providers and Potential Investors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Gliomas
  • Mixed neuronal-glial tumors
  • Embryonal tumors
  • Choroid plexus papilloma/carcinoma
  • Non-neuroepithelial tissue tumors
  • Meningeal Tumors
  • Others
By Application
  • Hospitals And Clinics
  • Medical Research Centers
  • Academic Institutes
  • Others
By Diagnosis
  • Imaging Tests
  • Brain or Spinal Cord Tumor Biopsy
  • Others

By Surgery
  • Therapies
  • Drug treatment
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Cases of Pediatric Tumors Are Increasing Globally
      • 3.2.2. Advanced Diagnostic Technology and New Treatments
      • 3.2.3. Rising Healthcare Infrastructure
      • 3.2.4. Extended Insurance Cover
      • 3.2.5. Government Initiatives
      • 3.2.6. Emerging Economies
    • 3.3. Market Challenges
      • 3.3.1. The High cost Associated with Pediatrics Brain Tumor Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pediatric Brain Tumor, by Type, Application, Diagnosis , Surgery and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Pediatric Brain Tumor (Value)
      • 5.2.1. Global Pediatric Brain Tumor by: Type (Value)
        • 5.2.1.1. Gliomas
        • 5.2.1.2. Mixed neuronal-glial tumors
        • 5.2.1.3. Embryonal tumors
        • 5.2.1.4. Choroid plexus papilloma/carcinoma
        • 5.2.1.5. Non-neuroepithelial tissue tumors
        • 5.2.1.6. Meningeal Tumors
        • 5.2.1.7. Others
      • 5.2.2. Global Pediatric Brain Tumor by: Application (Value)
        • 5.2.2.1. Hospitals And Clinics
        • 5.2.2.2. Medical Research Centers
        • 5.2.2.3. Academic Institutes
        • 5.2.2.4. Others
      • 5.2.3. Global Pediatric Brain Tumor by: Surgery (Value)
        • 5.2.3.1. Therapies
        • 5.2.3.2. Drug treatment
        • 5.2.3.3. Others
      • 5.2.4. Global Pediatric Brain Tumor Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Pediatric Brain Tumor: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AbbVie Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Akorn, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Agios, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Baxter (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bayer AG (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Epizyme, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Novartis AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Mylan N.V. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Pediatric Brain Tumor Sale, by Type, Application, Diagnosis , Surgery and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Pediatric Brain Tumor (Value)
      • 7.2.1. Global Pediatric Brain Tumor by: Type (Value)
        • 7.2.1.1. Gliomas
        • 7.2.1.2. Mixed neuronal-glial tumors
        • 7.2.1.3. Embryonal tumors
        • 7.2.1.4. Choroid plexus papilloma/carcinoma
        • 7.2.1.5. Non-neuroepithelial tissue tumors
        • 7.2.1.6. Meningeal Tumors
        • 7.2.1.7. Others
      • 7.2.2. Global Pediatric Brain Tumor by: Application (Value)
        • 7.2.2.1. Hospitals And Clinics
        • 7.2.2.2. Medical Research Centers
        • 7.2.2.3. Academic Institutes
        • 7.2.2.4. Others
      • 7.2.3. Global Pediatric Brain Tumor by: Surgery (Value)
        • 7.2.3.1. Therapies
        • 7.2.3.2. Drug treatment
        • 7.2.3.3. Others
      • 7.2.4. Global Pediatric Brain Tumor Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pediatric Brain Tumor: by Type(USD Million)
  • Table 2. Pediatric Brain Tumor Gliomas , by Region USD Million (2018-2023)
  • Table 3. Pediatric Brain Tumor Mixed neuronal-glial tumors , by Region USD Million (2018-2023)
  • Table 4. Pediatric Brain Tumor Embryonal tumors , by Region USD Million (2018-2023)
  • Table 5. Pediatric Brain Tumor Choroid plexus papilloma/carcinoma , by Region USD Million (2018-2023)
  • Table 6. Pediatric Brain Tumor Non-neuroepithelial tissue tumors , by Region USD Million (2018-2023)
  • Table 7. Pediatric Brain Tumor Meningeal Tumors , by Region USD Million (2018-2023)
  • Table 8. Pediatric Brain Tumor Others , by Region USD Million (2018-2023)
  • Table 9. Pediatric Brain Tumor: by Application(USD Million)
  • Table 10. Pediatric Brain Tumor Hospitals And Clinics , by Region USD Million (2018-2023)
  • Table 11. Pediatric Brain Tumor Medical Research Centers , by Region USD Million (2018-2023)
  • Table 12. Pediatric Brain Tumor Academic Institutes , by Region USD Million (2018-2023)
  • Table 13. Pediatric Brain Tumor Others , by Region USD Million (2018-2023)
  • Table 14. Pediatric Brain Tumor: by Surgery(USD Million)
  • Table 15. Pediatric Brain Tumor Therapies , by Region USD Million (2018-2023)
  • Table 16. Pediatric Brain Tumor Drug treatment , by Region USD Million (2018-2023)
  • Table 17. Pediatric Brain Tumor Others , by Region USD Million (2018-2023)
  • Table 18. South America Pediatric Brain Tumor, by Country USD Million (2018-2023)
  • Table 19. South America Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 20. South America Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 21. South America Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 22. South America Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 23. Brazil Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 24. Brazil Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 25. Brazil Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 26. Brazil Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 27. Argentina Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 28. Argentina Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 29. Argentina Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 30. Argentina Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 31. Rest of South America Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 32. Rest of South America Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 33. Rest of South America Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 34. Rest of South America Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 35. Asia Pacific Pediatric Brain Tumor, by Country USD Million (2018-2023)
  • Table 36. Asia Pacific Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 37. Asia Pacific Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 38. Asia Pacific Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 39. Asia Pacific Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 40. China Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 41. China Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 42. China Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 43. China Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 44. Japan Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 45. Japan Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 46. Japan Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 47. Japan Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 48. India Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 49. India Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 50. India Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 51. India Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 52. South Korea Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 53. South Korea Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 54. South Korea Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 55. South Korea Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 56. Taiwan Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 57. Taiwan Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 58. Taiwan Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 59. Taiwan Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 60. Australia Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 61. Australia Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 62. Australia Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 63. Australia Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 68. Europe Pediatric Brain Tumor, by Country USD Million (2018-2023)
  • Table 69. Europe Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 70. Europe Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 71. Europe Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 72. Europe Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 73. Germany Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 74. Germany Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 75. Germany Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 76. Germany Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 77. France Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 78. France Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 79. France Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 80. France Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 81. Italy Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 82. Italy Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 83. Italy Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 84. Italy Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 85. United Kingdom Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 86. United Kingdom Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 87. United Kingdom Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 88. United Kingdom Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 89. Netherlands Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 90. Netherlands Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 91. Netherlands Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 92. Netherlands Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 93. Rest of Europe Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 94. Rest of Europe Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 95. Rest of Europe Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 96. Rest of Europe Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 97. MEA Pediatric Brain Tumor, by Country USD Million (2018-2023)
  • Table 98. MEA Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 99. MEA Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 100. MEA Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 101. MEA Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 102. Middle East Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 103. Middle East Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 104. Middle East Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 105. Middle East Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 106. Africa Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 107. Africa Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 108. Africa Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 109. Africa Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 110. North America Pediatric Brain Tumor, by Country USD Million (2018-2023)
  • Table 111. North America Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 112. North America Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 113. North America Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 114. North America Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 115. United States Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 116. United States Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 117. United States Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 118. United States Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 119. Canada Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 120. Canada Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 121. Canada Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 122. Canada Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 123. Mexico Pediatric Brain Tumor, by Type USD Million (2018-2023)
  • Table 124. Mexico Pediatric Brain Tumor, by Application USD Million (2018-2023)
  • Table 125. Mexico Pediatric Brain Tumor, by Diagnosis USD Million (2018-2023)
  • Table 126. Mexico Pediatric Brain Tumor, by Surgery USD Million (2018-2023)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Pediatric Brain Tumor: by Type(USD Million)
  • Table 137. Pediatric Brain Tumor Gliomas , by Region USD Million (2025-2030)
  • Table 138. Pediatric Brain Tumor Mixed neuronal-glial tumors , by Region USD Million (2025-2030)
  • Table 139. Pediatric Brain Tumor Embryonal tumors , by Region USD Million (2025-2030)
  • Table 140. Pediatric Brain Tumor Choroid plexus papilloma/carcinoma , by Region USD Million (2025-2030)
  • Table 141. Pediatric Brain Tumor Non-neuroepithelial tissue tumors , by Region USD Million (2025-2030)
  • Table 142. Pediatric Brain Tumor Meningeal Tumors , by Region USD Million (2025-2030)
  • Table 143. Pediatric Brain Tumor Others , by Region USD Million (2025-2030)
  • Table 144. Pediatric Brain Tumor: by Application(USD Million)
  • Table 145. Pediatric Brain Tumor Hospitals And Clinics , by Region USD Million (2025-2030)
  • Table 146. Pediatric Brain Tumor Medical Research Centers , by Region USD Million (2025-2030)
  • Table 147. Pediatric Brain Tumor Academic Institutes , by Region USD Million (2025-2030)
  • Table 148. Pediatric Brain Tumor Others , by Region USD Million (2025-2030)
  • Table 149. Pediatric Brain Tumor: by Surgery(USD Million)
  • Table 150. Pediatric Brain Tumor Therapies , by Region USD Million (2025-2030)
  • Table 151. Pediatric Brain Tumor Drug treatment , by Region USD Million (2025-2030)
  • Table 152. Pediatric Brain Tumor Others , by Region USD Million (2025-2030)
  • Table 153. South America Pediatric Brain Tumor, by Country USD Million (2025-2030)
  • Table 154. South America Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 155. South America Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 156. South America Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 157. South America Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 158. Brazil Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 159. Brazil Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 160. Brazil Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 161. Brazil Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 162. Argentina Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 163. Argentina Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 164. Argentina Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 165. Argentina Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 166. Rest of South America Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 167. Rest of South America Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 168. Rest of South America Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 169. Rest of South America Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 170. Asia Pacific Pediatric Brain Tumor, by Country USD Million (2025-2030)
  • Table 171. Asia Pacific Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 172. Asia Pacific Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 173. Asia Pacific Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 174. Asia Pacific Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 175. China Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 176. China Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 177. China Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 178. China Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 179. Japan Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 180. Japan Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 181. Japan Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 182. Japan Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 183. India Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 184. India Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 185. India Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 186. India Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 187. South Korea Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 188. South Korea Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 189. South Korea Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 190. South Korea Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 191. Taiwan Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 192. Taiwan Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 193. Taiwan Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 194. Taiwan Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 195. Australia Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 196. Australia Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 197. Australia Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 198. Australia Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 199. Rest of Asia-Pacific Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 200. Rest of Asia-Pacific Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 201. Rest of Asia-Pacific Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 202. Rest of Asia-Pacific Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 203. Europe Pediatric Brain Tumor, by Country USD Million (2025-2030)
  • Table 204. Europe Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 205. Europe Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 206. Europe Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 207. Europe Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 208. Germany Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 209. Germany Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 210. Germany Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 211. Germany Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 212. France Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 213. France Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 214. France Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 215. France Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 216. Italy Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 217. Italy Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 218. Italy Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 219. Italy Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 220. United Kingdom Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 221. United Kingdom Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 222. United Kingdom Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 223. United Kingdom Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 224. Netherlands Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 225. Netherlands Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 226. Netherlands Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 227. Netherlands Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 228. Rest of Europe Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 229. Rest of Europe Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 230. Rest of Europe Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 231. Rest of Europe Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 232. MEA Pediatric Brain Tumor, by Country USD Million (2025-2030)
  • Table 233. MEA Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 234. MEA Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 235. MEA Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 236. MEA Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 237. Middle East Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 238. Middle East Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 239. Middle East Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 240. Middle East Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 241. Africa Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 242. Africa Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 243. Africa Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 244. Africa Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 245. North America Pediatric Brain Tumor, by Country USD Million (2025-2030)
  • Table 246. North America Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 247. North America Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 248. North America Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 249. North America Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 250. United States Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 251. United States Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 252. United States Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 253. United States Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 254. Canada Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 255. Canada Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 256. Canada Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 257. Canada Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 258. Mexico Pediatric Brain Tumor, by Type USD Million (2025-2030)
  • Table 259. Mexico Pediatric Brain Tumor, by Application USD Million (2025-2030)
  • Table 260. Mexico Pediatric Brain Tumor, by Diagnosis USD Million (2025-2030)
  • Table 261. Mexico Pediatric Brain Tumor, by Surgery USD Million (2025-2030)
  • Table 262. Research Programs/Design for This Report
  • Table 263. Key Data Information from Secondary Sources
  • Table 264. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pediatric Brain Tumor: by Type USD Million (2018-2023)
  • Figure 5. Global Pediatric Brain Tumor: by Application USD Million (2018-2023)
  • Figure 6. Global Pediatric Brain Tumor: by Surgery USD Million (2018-2023)
  • Figure 7. South America Pediatric Brain Tumor Share (%), by Country
  • Figure 8. Asia Pacific Pediatric Brain Tumor Share (%), by Country
  • Figure 9. Europe Pediatric Brain Tumor Share (%), by Country
  • Figure 10. MEA Pediatric Brain Tumor Share (%), by Country
  • Figure 11. North America Pediatric Brain Tumor Share (%), by Country
  • Figure 12. Global Pediatric Brain Tumor share by Players 2023 (%)
  • Figure 13. Global Pediatric Brain Tumor share by Players (Top 3) 2023(%)
  • Figure 14. Global Pediatric Brain Tumor share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott. (United States) Revenue: by Geography 2023
  • Figure 18. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. AbbVie Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Akorn, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Akorn, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Agios, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Agios, Inc. (United States) Revenue: by Geography 2023
  • Figure 24. Baxter (United States) Revenue, Net Income and Gross profit
  • Figure 25. Baxter (United States) Revenue: by Geography 2023
  • Figure 26. Bayer AG (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bayer AG (United States) Revenue: by Geography 2023
  • Figure 28. Epizyme, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Epizyme, Inc. (United States) Revenue: by Geography 2023
  • Figure 30. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 32. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Mylan N.V. (United States) Revenue: by Geography 2023
  • Figure 34. Global Pediatric Brain Tumor: by Type USD Million (2025-2030)
  • Figure 35. Global Pediatric Brain Tumor: by Application USD Million (2025-2030)
  • Figure 36. Global Pediatric Brain Tumor: by Surgery USD Million (2025-2030)
  • Figure 37. South America Pediatric Brain Tumor Share (%), by Country
  • Figure 38. Asia Pacific Pediatric Brain Tumor Share (%), by Country
  • Figure 39. Europe Pediatric Brain Tumor Share (%), by Country
  • Figure 40. MEA Pediatric Brain Tumor Share (%), by Country
  • Figure 41. North America Pediatric Brain Tumor Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott. (United States)
  • AbbVie Inc. (United States)
  • Akorn, Inc. (United States)
  • Agios, Inc. (United States)
  • Baxter (United States)
  • Bayer AG (United States)
  • Epizyme, Inc. (United States)
  • Novartis AG (Switzerland)
  • Mylan N.V. (United States)
Select User Access Type

Key Highlights of Report


Jul 2024 217 Pages 50 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pediatric Brain Tumor Market Quantitative research analysis
Global Pediatric Brain Tumor Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott. (United States), AbbVie Inc. (United States), Akorn, Inc. (United States), Agios, Inc. (United States), Baxter (United States), Bayer AG (United States), Epizyme, Inc. (United States), Novartis AG (Switzerland) and Mylan N.V. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for Pediatric Brain Tumor Market during projected period 2023-2030.
The Pediatric Brain Tumor market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Pediatric Brain Tumor Market to reach USD1717.52 Million by 2030.

Know More About Global Pediatric Brain Tumor Market Report?

Have a Query? Click Here

Other Related Reports

Head and Neck Cancer Diagnostics Comprehensive Study by Type (Diagnostic imaging equipment, Endoscopy screening equipment, Bioscopy screening tests, Blood tests, Dental diagnostic), Application (Hosp...
$ 3750
Implantable Heart Pacemaker Comprehensive Study by Type (Single Chamber, Dual-Chamber, Biventricular Pacemaking), Application (Heart Block, Sick Sinus Syndrome, Diagnosing Heart Diseases, Others), Pa...
$ 3650
Orthopaedics Comprehensive Study by Application (Fracture Management, Joint Replacement, Orthopedic Surgery, Pediatric Assessment, Pediatric Assessment), Area of Treatment (Trauma, Spine, Knee, Hip),...
$ 3350
Type 1 Diabetes Comprehensive Study by Application (Hospitals, Diagnostic clinics), End Users (Adults, Hospitals and Clinics, Homecare Providers), Product (Insulin, Blood Glucose Monitoring Devices, ...
$ 3500
Food Allergy Comprehensive Study by Type (Corn Allergy, Egg Allergy, Fish Allergy, Meat Allergy, Milk Allergy, Peanut Allergy, Shellfish Allergy, Soy Allergy, Tree Nut Allergy, Wheat Allergy, Others)...
$ 3750
Chemical Peel Comprehensive Study by Type (Light Chemical Peel, Medium Chemical Peel, Deep Chemical Peel), Application (Dermatology Clinics, Hospitals, Others), Chemicals (Alpha-hydroxy Acids (AHAs),...
$ 3450